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Editorial
UNIVERSITY CHAIRS IN CLINICAL ONCOLOGY
For some years now the Cancer Research Campaign has been conscious that it is
supporting less research at the clinical level than it would wish. Discussions at the
Campaign's Scientific Committee showed general agreement that there is a need on the
one hand for clinicians treating cancer patients to have the benefit of close association
with scientists involved in cancer research at laboratory level; and on the other hand
for laboratory workers to be kept in touch with the practicalities of clinical cancer
investigation and treatment by similar close association with practising clinicians.
The need for this association is self-evident when such products of the laboratory as
diagnostic tests or therapeutic agents reach the stage of clinical assessment, but few
will doubt that more subtle though less easily defined benefits can result from a satis-
factory day to day collaboration between the two types ofworker.
It was considerations such as these that led the Campaign, a year ago, to establish
a Chair of Medicine in the University of London, tenable at the Institute of Cancer
Research. The first Professor, who on this occasion has been appointed on a Visiting
basis, is Dr P. K. Bondy of Yale University. He took up his appointment in July of
this year. It was announced at the Annual General Meeting of the Campaign on the
fourth of July that the Campaign now proposes to extend this initiative by setting up
further Chairs in appropriate centres as occasion arises, amoun-ting perhaps to five more
Chairs over the next decade. These Chairs, and the departments that evolve around
them, could serve many useful functions in addition to the integration of clinical and
laboratory work that has been mentioned. They could serve to attract into whole
time work in the investigation and treatment of cancer distinguished senior clinicians
who at present can give only part of their attention to this field: they can provide
training centres where clinicians can acquire expertise in the handling of the rapidly
evolving and expanding field of cancer therapy: and they can provide a graded career
structure to encourage young doctors to enter the growing specialty ofclinical oncology.
But perhaps most important will be the opportunities these Chairs can provide for
more clinical cancer research and for the accelerated application oflaboratory advances
to clinical practice.
The siting of the proposed Chairs will be influenced by a number offactors, and no
doubt there will be considerable variation in detail of the set-up achieved in different
centres. Some are likely to be established in relationship to the Oncological Centres
which the Health Departments are already considering, but much will depend on the
Universities themselves. It is to be hoped that those faculties with something special
to contribute in this area will grasp the initiative and approach the Campaign with
imaginative and original proposals.
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